HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency.

Abstract
Phenobarbital or potassium bromide (KBr) add-on treatment decreases the average monthly seizure frequency in dogs with idiopathic epilepsy resistant to a maximum dose of imepitoin. The importance of continued administration of imepitoin in these dogs is currently unknown. The goal of this study was to assess whether imepitoin withdrawal would destabilize epileptic seizure control. In this prospective clinical trial epileptic seizure control was evaluated by comparing the monthly seizure frequency of 13 dogs with well-controlled idiopathic epilepsy receiving a combination of imepitoin and phenobarbital (n=4), imepitoin and KBr (n=7), and imepitoin, phenobarbital and KBr (n=2) during a period of 3-6 months (pre-withdrawal period), with a follow-up period of 9-12 months after withdrawal of imepitoin (post-withdrawal period). Adverse effects were also recorded before and after withdrawal of imepitoin. Imepitoin was tapered off over 3 months as follows: 20mg/kg twice daily for 1 month, then 10mg/kg twice daily for 1 month, then once daily for 1 month. Withdrawal of imepitoin did not increase monthly seizure frequency (P=0.9). Moreover, all owners reported improvement in the adverse effects experienced by their dog after withdrawal of imepitoin. Imepitoin withdrawal in epileptic dogs that were well-controlled with imepitoin and phenobarbital and/or KBr did not worsen epileptic seizure control, and possibly decreased antiepileptic treatment-related adverse effects. However, a worsening of seizure frequency could occur in individual cases.
AuthorsK Stee, V Martlé, B J G Broeckx, E Royaux, L Van Ham, S F M Bhatti
JournalVeterinary journal (London, England : 1997) (Vet J) Vol. 230 Pg. 1-5 (Dec 2017) ISSN: 1532-2971 [Electronic] England
PMID29208209 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier Ltd. All rights reserved.
Chemical References
  • AWD 131-138
  • Anticonvulsants
  • Bromides
  • Imidazoles
  • Potassium Compounds
  • potassium bromide
  • Phenobarbital
Topics
  • Animals
  • Anticonvulsants (administration & dosage, therapeutic use)
  • Bromides (administration & dosage, therapeutic use)
  • Dog Diseases (drug therapy)
  • Dogs
  • Drug Therapy, Combination (veterinary)
  • Epilepsy (drug therapy, veterinary)
  • Female
  • Imidazoles (administration & dosage, therapeutic use)
  • Male
  • Phenobarbital (administration & dosage, therapeutic use)
  • Potassium Compounds (administration & dosage, therapeutic use)
  • Seizures (drug therapy, veterinary)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: